These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine. Robertson CA, Greenberg DP, Hedrick J, Pichichero M, Decker MD, Saunders M. Vaccine; 2016 Oct 17; 34(44):5273-5278. PubMed ID: 27642132 [Abstract] [Full Text] [Related]
4. Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same Vaccines. Vesikari T, Forsten A, Bianco V, Van der Wielen M, Miller JM. Pediatr Infect Dis J; 2015 Dec 17; 34(12):e298-307. PubMed ID: 26780033 [Abstract] [Full Text] [Related]
12. Antibody persistence and booster response following MenACWY-CRM vaccination in children as assessed by two different assay methods. Klein NP, Block SL, Essink B, Barbi S, Smolenov I, Keshavan P. Vaccine; 2019 Jul 26; 37(32):4460-4467. PubMed ID: 31279564 [Abstract] [Full Text] [Related]
15. Safety and immunogenicity of meningococcal ACWY CRM197-conjugate vaccine in children, adolescents and adults in Russia. Ilyina N, Kharit S, Namazova-Baranova L, Asatryan A, Benashvili M, Tkhostova E, Bhusal C, Arora AK. Hum Vaccin Immunother; 2014 Jul 26; 10(8):2471-81. PubMed ID: 25424958 [Abstract] [Full Text] [Related]
16. Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study. Klein NP, Habanec T, Kosina P, Shah NR, Kolhe D, Miller JM, Hezareh M, Van der Wielen M. Vaccine; 2018 Apr 19; 36(17):2356-2363. PubMed ID: 29576307 [Abstract] [Full Text] [Related]
17. Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial. van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Knol MJ, Stoof SP, Sanders EAM, Berbers GAM. Vaccine; 2017 Aug 24; 35(36):4745-4752. PubMed ID: 28668575 [Abstract] [Full Text] [Related]
20. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers. McVernon J, Nolan T, Richmond P, Reynolds G, Nissen M, Lambert SB, Marshall H, Papa T, Rehm C. Pediatr Infect Dis J; 2012 Jan 24; 31(1):e15-23. PubMed ID: 22094636 [Abstract] [Full Text] [Related] Page: [Next] [New Search]